Recent Security Class Actions
Acer Therapeutics Inc. Common Stock (DE) (NASDAQ: ACER)
Company Name:Acer Therapeutics Inc. Common Stock (DE)
Stock Symbol:NASDAQ: ACER
Class Period Start:09/25/2017
Class Period End (inclusive):06/24/2019
Filing Deadline:08/30/2019
According to the Complaint, Acer is a pharmaceutical company that purportedly focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer’s pipeline includes, inter alia, EDSIVO (celiprolol) for the treatment of vEDS in patients with a confirmed type III collagen mutation.
